PI3K inhibitors are finally coming of age
Bart Vanhaesebroeck, Matthew W. D. Perry, Jennifer R. Brown, Fabrice André, Klaus Okkenhaug
Topics & Concepts
PI3K/AKT/mTOR pathwayCancerMedicinePharmacologyCancer researchBiologySignal transductionInternal medicineBiochemistryPI3K/AKT/mTOR signaling in cancerChronic Lymphocytic Leukemia ResearchLung Cancer Treatments and Mutations